24 Sep 1999
| by DAVID MCCORMACK
Reuters and broadcast PR specialist World Television are launching
a new satellite TV news service on health issues this month. Reuters
World Health will deliver TV news releases to over 1,500 broadcasters.
The service is available to all health organisations and pharmaceutical
companies.
10 Sep 1999
| by STEVE BELL
Boots The Chemists and Hollinger Digital have handed a pounds
100,000 fee consumer and trade PR account to Powerhouse to promote new
women-focused internet web site, handbag.com.
10 Sep 1999
| by SOPHIE BARKER
ATHENS: Top three pharmaceuticals firm AstraZeneca has selected
Hill and Knowlton as its first corporate PR agency in Greece.
03 Sep 1999
| by SOPHIE BARKER
Swiss healthcare company Roche has promoted Sarah Ridout to the
newly created role of UK corporate affairs director in an overhaul of
the company s PR practices.
03 Sep 1999
| by SOPHIE BARKER
The Shire Hall Group, the UK s second largest PR medical
specialist, is to remain an independent entity within its new parent
company, WPP, rather than being absorbed into an existing PR
network.
03 Sep 1999
| by NICK PURDOM
It is estimated that one third of drugs in the US will be coming
off patent in the next five years. For manufacturers this has serious
implications. In the UK, for example, 47 per cent of AstraZeneca s drug
sales come from two products - Zestril and Losec - both of which go off
patent in 2002.
20 Aug 1999
| by DAVID MCCORMACK
CPR Worldwide has been appointed to handle Glaxo Wellcome s HIV
portfolio after winning a three-way pitch. PR for the HIV portfolio was
previously handled in-house. CPR s appointment marks the conclusion of a
wide-ranging review of Glaxo Wellcome s PR arrangements (PR Week, 30
April) triggered by the...
20 Aug 1999
| by JULIETTE GARSIDE
Greenlines Healthcare Communications has recruited Shandwick
Welbeck healthcare director Nigel Hayward as managing director.
20 Aug 1999
| by MARK JOHNSON
The Association of the British Pharmaceutical Industry (ABPI), the
trade body which lobbies for full patient access to treatments on behalf
of pharmaceutical companies in the UK, has reacted to devolution with
plans to open a dedicated Scottish office, and is casting its net to
find a PR heavyweight...